The monthly intracisternal inoculation of young adult New Zealand white rabbits with low-dose (100 u.g) aluminum chloride induces aggregates of phosphorylated neurofilament that mimics the intraneuronal inclusions of amyotrophic lateral sclerosis. The chronic progressive myelopathy and topographically-specific motor neuron degeneration that occurs in the absence of suppressions of neurofilament messenger RNA levels in this model contrasts with the acute fulminant encephalomyelopathy and nonspecific gene suppressions that occur subsequent to high-dose (1000 u.g) aluminum chloride inoculations. Further analysis of this unique model of chronic motor system degeneration can be expected to provide additional insights into the pathogenesis of amyotrophic lateral sclerosis. RESUME: Degenerescence chronique du neurone moteur induite par l'aluminium : aspects cliniques, neuropathologiques et biologie moleculaire. Une inoculation mensuelle intracisternale d'une petite dose de chlorure d'aluminium (100 |ig), chez de jeunes lapins blancs adultes de Nouvelle Zelande, induit l'apparition d'agregats de neurofilaments phosphoryles qui simulent les inclusions intraneuronales de la sclerose laterale amyotrophique. La myelopathic progressive chronique et la degenerescence du neurone moteur a topographie specifique, qui survient en l'absence de suppression des niveaux d'ARN messager du neurofilament dans ce modele, constraste avec l'encephalomyelopathie aigue fulminante et la suppression genique non-specifique qui surviennent suite a l'inoculation de hautes doses de chlorure d'aluminium (1000 jug). Une analyse plus poussee de ce modele unique ce degenerescence chronique du systeme moteur laisse presager qu'on en tirera une comprehension additionnelle de la pathogenese de la sclerose laterale amyotrophique.
Amyotrophic lateral sclerosis (ALS) is a relentlessly progressive, uniformly fatal disorder of the neuronal cytoskeleton affecting the upper and lower motor neurons. The disease has a world-wide distribution and increasing age-related incidence rates of 1.6 to 2.4/100,000. 14 Death occurs within 2.5 years in 50% of cases and 90-95% are deceased within the first decade. 5 -6 As a direct consequence of our studies of ALS in the Western Pacific where original incidence rates were at least 50 times higher than worldwide rates, 7 " 10 we have undertaken the long-term development of models of chronic, experimentallyincluded neuronal degeneration, both in vivo and in vitro, in an attempt to understand the cellular and molecular pathogenic mechanisms of ALS.
Irrespective of the clinical variant studied (classical sporadic, familial or Western Pacific), the neuropathological hallmark of ALS is a loss of upper and lower motor neurons that is topographically specific (e.g. sparing of Onuf's nucleus and cranial nuclei III, IV, VI). 11 Whereas neuronal loss is a later event in the disease process, intracytoplasmic inclusions and neuroaxonal swellings consisting of interwoven skeins or parallel arrays of morphologically normal phosphorylated neurofilament within degenerating motor neurons are invariably early neuropathological findings. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] While there are additional neuropathological features that further distinguish between the clinical variants (e.g. paired helical filaments in Western Pacific ALS; 22 ' 23 Clarke's nucleus and dorsal spinocerebellar tract degeneration in some cases of familial ALS), 24 -25 these inclusions suggest that ALS is a cytoskeletal disorder with an impairment in biosynthesis or catabolism of the neurofilament triplet protein as a common biological process underlying all of the clinical variants. Extensive epidemiological, genetic, cellular and molecular studies of the Western Pacific foci of ALS have provided insights into this process and strongly implicate environmental factors in its etiology, specifically the interaction of calcium and aluminum in the disease process. 9 " 10 The resulting hypothesis that an environmental deficiency of calcium coupled with high aluminum induces a form of secondary hyperparathyrodisim accompanied by enhanced gastrointestinal absorption of aluminum has been supported by a large body of data over the past three decades, as well as by the experimental induction of neuropathological lesions reminiscent of those seen in ALS in nonhuman primates (cynomolgus monkeys and Japanese macaques) chronically fed a hypocalcemic, aluminum-supplemented diet. 26 " 28 Experimentally, although aggregates of phosphorylated neurofilament with ultrastructural characteristics reminiscent of ALS can be induced with single inoculations of large (1000 |ig or greater) doses of organic or inorganic aluminum compounds in a variety of experimental hosts, these conventional models of aluminum neurotoxicity are inappropriate for the study of the process of neurofilamentous degeneration in a chronic neurodegenerative disorder such as ALS. 29 Invariably, these "acute" models are accompanied by a fulminant encephalopathy marked by seizures, quadraparesis and death (10 to 14 days post inoculation), and a diffuse, nonspecific neuronal degeneration with suppression of gene transcription not thought to occur in ALS. [30] [31] [32] [33] To circumvent these difficulties, we have developed an experimental model of a slowly progressive, aluminuminduced myelopathy that mimics to a large extent the clinical and topographic specificity of motor system degeneration in human ALS. Following repeated intracisternal inoculations of low dose (100 jug) A1C1 3 at 4 weekly intervals over the course of eight months in young adult New Zealand white rabbits (age 8-9 weeks), encephalopathic signs, widespread neuronal degeneration and suppressions of neurofilament mRNA levels seen in the "acute" model do not occur. 34 -35 Neuropathologically, there was extensive degeneration of spinal motor nuclei with argentophilic globular inclusions within motor neuron perikarya, dendrites and axonal processes. Neurofibrillary tangle-like argentophilic inclusions were consistently present in the gigantocellularis, reticularis, raphe and trapezoid nuclei, but only rarely present in the doral and ventral subiculum, parasubiculum and anterior thalamus, and never found in the cerebral cortex, substantia nigra, locus ceruleus, or ferebellum. Ultrastructurally, these inclusions consisted of straight or interwoven skeins of 10 nm filaments.
Immunocytochemically, the neurofilamentous inclusions demonstrated a spectrum of immunoreactivity with monoclonal antibodies against phosphorylated and nonphosphorylated epitopes of neurofilament subunit proteins -features reminiscent of the immunohistochemical studies of ALS reported by Schmidt et al 18 . While many inclusions are intensely immunoreactive with antibodies recognizing phosphorylated epitopes of neurofilament, inclusions are also present which demonstrate no immunoreactivity or are only faintly immunoreactive. Some inclusions react only to antibodies recognizing nonphosphorylated epitopes. Axonal spheroids and a variable number of intracytoplasmic inclusions (< 20%) are also uniquely immunoreactive to SMI 34, an antibody which recognized an "age-related" phosphorylation epitope of neurofilament 36 but does not recognize acute aluminum-induced neurofilamentous inclusions. 37 Molecular studies using our model of chronic aluminum intoxication demonstrated that alterations in gene transcription do not occur -unlike that reported for the acute model. In preliminary experiments, we have correlated the dose of A1C1 3 administered (1000, 750, 500, 200 or 100 (ig A1C1 3 intracister-nally) with the presence of clinical deficits, extent of neurofilamentous inclusions (topographically and percentages of neurons involved per nuclear group), and the relative degree of low and intermediate weight neurofilament subunit protein mRNA suppression (compared to actin and tubulin mRNA levels by Northern blot analysis) at 48 hours post inoculation. 35 Neither suppression of neurofilament mRNA levels or inclusion development occurred at the 100 to 250 fig dose.
In order to demonstrate that the in vivo selectivity of neurofilamentous inclusions observed in the chronic model reflect neuron-specific thresholds of toxicity, we compared the responses to dissociated hippocampal and motor neurons in vitro to aluminum challenge. When cultured under identical conditions and similar states of maturation in a chemically-defined media, motor neurons exhibited a 10 fold greater sensitivity to aluminum toxicity than hippocampal neurons as measured by morphological criteria -e.g. cell degeneration, death or appearance of inclusions. 38 -39 Although electrophysiological alterations may precede the development of neuropathological changes following aluminum administration, 40 the striking disparity in sensitivity between motor neurons (10 uM A1C1 3 ) and hippocampal neurons (100 U.M A1C1 3 ) indicate neuron-specific thresholds of aluminum toxicity.
Although the exact mechanisms of aluminum intoxication as they relate to the process of neuronal degeneration have yet to be clearly defined, multiple biological effects of aluminum have been identified in human, animal and plant species. '0,41-46 Those which are pertinent to altered neurofilament processing include the binding of aluminum to nuclear chromatin, 47 -48 alterations in cAMP activity with subsequent increases in the rate of neurofilament phosphorylation, [49] [50] [51] direct covalent binding of aluminum to phosphorylated neurofilament epitopes, 52 inhibition of calmodulin, 5 3 5 6 inhibition of microtubule assembly, 57 impairment of slow axonal transport, ' and inhibition of neurofilament loading onto the axonal transport system. [62] [63] While these mechanisms are not mutually exclusive, they may be dependent on host genetics, the chemical form, route and frequency of aluminum administration, or the cell types analyzed. Ultimately, it is likely that one or more separate defects in neurofilament biosynthesis or catabolism lead to aberrant accumulations of neurofilament which are morphologically indistinguishable and neuron-specific. Based on our observations, and those of others demonstrating alterations in the gross morphological appearance of aluminum-induced inclusions over time, [64] [65] [66] we hypothesize that, once deposited, neurofilamentous inclusions are subject to a dynamic chemical remodelling of their phosphorylation state.
Current in vivo studies are attempting to identify the mechanisms by which the phosphorylation states of neurofilamentous inclusions in chronic aluminum toxicity are altered. It is likely that the same protein kinase is responsible for normal phosphorylation and for the phosphorylation by the SMI 34 antibody (V. Ingram, personal communication). This raises the question of whether the protein kinase itself is altered in some fashion (for which kinetic studies will provide some insight) or if the site of phosphorylation is altered as suggested for tau proteins in Alzheimer disease. 67 -68 Ultimately, determining if aberrant protein phosphorylation is crucial to the induction of motor neuronal degeneration will provide an insight into the pathogenesis of ALS.
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Future in vivo and in vitro studies should continue to address the cellullar and molecular mechanisms of chronic low-dose aluminum intoxication leading to the induction of neurofilamentous inclusions. Such studies should not only include attempts to understand the molecular biology of altered neurofilament gene expression, transcription, translation and post-translational modification, but also the identification of aluminum transport mechanisms, neuronal metalloenzyme receptor sites and the effects of various aluminum species, chemical remodelling of aluminum complexes and calcium-aluminum interactions of the induction of neuronal degeneration.
